Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
Journal of Vascular Surgery|November 4, 2017
Standard "off-the-shelf" multibranched thoracoabdominal endograft in urgent and elective patients with single and staged procedures in a multicenter experienceRoberto Silingardi, Stefano Gennai, Nicola Leone, et al.Diagnostics (Basel, Switzerland)|April 3, 2021
The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort StudyAngela Toss, Claudia Piombino, Elena Tenedini, et al.JCO Global Oncology|May 5, 2025
Cause-Specific Mortality in a Cohort of 1,435 Patients With Hodgkin Lymphoma Treated Between 1985 and 2014: A Nationwide Chilean Cohort StudyMaria Elena Cabrera, Monica Civallero, Yana Stepanishyna, et al.Clinical Lymphoma & Myeloma|May 2, 2009
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trialEmilio Iannitto, Viviana Minardi, Paolo G Gobbi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi TrialMassimo Federico, Stefano Luminari, Emilio Iannitto, et al.Leukemia & Lymphoma|September 8, 2011
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano LinfomiFrancesco Merli, Stefano Luminari, Giuseppe Rossi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor projectMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2013
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana LinfomiMassimo Federico, Stefano Luminari, Alessandra Dondi, et al.American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.Leukemia & Lymphoma|June 21, 2012
Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective studyAngelo M Carella, Carmino A de Souza, Stefano Luminari, et al.Pageof 13